Reviewed,
UniProtKB/Swiss-Prot P08572 (CO4A2_HUMAN)
Last modified
November 24, 2009.
Version 117.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Collagen alpha-2(IV) chain Cleaved into the following chain: 1- Recommended name: Canstatin | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1712 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. Potently inhibits angiogenesis and tumor growth. Ref.13 |
| Subunit structure | There are six type IV collagen isoforms, alpha 1(IV)-alpha 6(IV), each of which can form a triple helix structure with 2 other chains to generate type IV collagen network. |
| Subcellular location | Secreted › extracellular space › extracellular matrix › basement membrane. |
| Domain | Alpha chains of type IV collagen have a non-collagenous domain (NC1) at their C-terminus, frequent interruptions of the G-X-Y repeats in the long central triple-helical domain (which may cause flexibility in the triple helix), and a short N-terminal triple-helical 7S domain. |
| Post-translational modification | Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains. Type IV collagens contain numerous cysteine residues which are involved in inter- and intramolecular disulfide bonding. 12 of these, located in the NC1 domain, are conserved in all known type IV collagens. The trimeric structure of the NC1 domains is stabilized by covalent bonds between Lys and Met residues By similarity. |
| Sequence similarities | Belongs to the type IV collagen family. Contains 1 collagen IV NC1 (C-terminal non-collagenous) domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Basement membrane Extracellular matrix Secreted |
| Coding sequence diversity | Polymorphism |
| Domain | Collagen Repeat Signal |
| PTM | Disulfide bond Glycoprotein Hydroxylation |
| Technical term | 3D-structure Complete proteome Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | extracellular matrix organization Ref.6 Non-traceable author statement. Source: UniProtKB negative regulation of angiogenesis Ref.13Inferred from direct assay. Source: UniProtKB |
| Cellular component | collagen type IV Ref.3 Ref.4 Traceable author statement. Source: UniProtKB |
| Molecular function | extracellular matrix structural constituent Ref.6 Traceable author statement. Source: UniProtKB protein bindingInferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 25 | 25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Propeptide | 26 – 183 | 158 | N-terminal propeptide (7S domain) | PRO_0000005824 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 184 – 1712 | 1529 | Collagen alpha-2(IV) chain | PRO_0000005825 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 1486 – 1712 | 227 | Canstatin | PRO_0000283775 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 1489 – 1712 | 224 | Collagen IV NC1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 184 – 1484 | 1301 | Triple-helical region | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 138 | 1 | N-linked (GlcNAc...) Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1504 ↔ 1593 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1537 ↔ 1590 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1549 ↔ 1555 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1612 ↔ 1708 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1646 ↔ 1705 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1658 ↔ 1665 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 517 | 1 | R → K: dbSNP rs7990383. Ref.3 | VAR_048796 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 683 | 1 | G → A: dbSNP rs3803230. Ref.3 | VAR_048797 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 718 | 1 | P → S: dbSNP rs9583500. | VAR_048798 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 471 | 1 | R → P in CAA29076. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1041 | 1 | V → L in AAA52043. Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1399 | 1 | V → I in CAA29098. Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1419 | 1 | M → I in CAA29098. Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1575 | 1 | M → I in AAA58422. Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1636 | 1 | G → V in AAA52043. Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1663 | 1 | G → H AA sequence Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1701 | 1 | H → G AA sequence Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1490 – 1495 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1497 – 1500 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1509 – 1522 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1525 – 1528 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1534 – 1536 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1537 – 1540 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1546 – 1550 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 1551 – 1553 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1554 – 1558 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1563 – 1568 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1580 – 1586 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1589 – 1597 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1599 – 1603 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1605 – 1608 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1616 – 1629 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1635 – 1637 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1643 – 1645 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1646 – 1649 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1655 – 1659 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 1660 – 1663 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1664 – 1666 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1672 – 1677 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1680 – 1684 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1691 – 1694 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1699 – 1701 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1704 – 1710 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The complete primary structure of the alpha 2 chain of human type IV collagen and comparison with the alpha 1(IV) chain." Hostikka S.L., Tryggvason K. J. Biol. Chem. 263:19488-19493(1988) [PubMed: 3198637] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "The DNA sequence and analysis of human chromosome 13." Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T. Ross M.T.Nature 428:522-528(2004) [PubMed: 15057823] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "Human basement membrane collagen (type IV). The amino acid sequence of the alpha 2(IV) chain and its comparison with the alpha 1(IV) chain reveals deletions in the alpha 1(IV) chain." Brazel D., Pollner R., Oberbaeumer I., Kuehn K. Eur. J. Biochem. 172:35-42(1988) [PubMed: 3345760] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-1042, VARIANTS LYS-517 AND ALA-683. Tissue: Placenta. |
| [4] | "The genes for the alpha 1(IV) and alpha 2(IV) chains of human basement membrane collagen type IV are arranged head-to-head and separated by a bidirectional promoter of unique structure." Poeschl E., Pollner R., Kuehn K. EMBO J. 7:2687-2695(1988) [PubMed: 2846280] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33. |
| [5] | "The structural genes for alpha 1 and alpha 2 chains of human type IV collagen are divergently encoded on opposite DNA strands and have an overlapping promoter region." Soininen R., Huotari M., Hostikka S.L., Prockop D.J., Tryggvason K. J. Biol. Chem. 263:17217-17220(1988) [PubMed: 3182844] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33. |
| [6] | "Identification of a novel sequence element in the common promoter region of human collagen type IV genes, involved in the regulation of divergent transcription." Fischer G., Schmidt C., Opitz J., Cully Z., Kuehn K., Poeschl E. Biochem. J. 292:687-695(1993) [PubMed: 8317999] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33. Tissue: Skin. |
| [7] | "Partial structure of the human alpha 2(IV) collagen chain and chromosomal localization of the gene (COL4A2)." Killen P.D., Francomano C.A., Yamada Y., Modi W.S., O'Brien S.J. Hum. Genet. 77:318-324(1987) [PubMed: 3692475] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1040-1712. Tissue: Placenta. |
| [8] | "Nucleotide sequence coding for the human type IV collagen alpha 2 chain cDNA reveals extensive homology with the NC-1 domain of alpha 1 (IV) but not with the collagenous domain or 3'-untranslated region." Hostikka S.L., Kurkinen M., Tryggvason K. FEBS Lett. 216:281-286(1987) [PubMed: 3582677] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1254-1712. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1351-1712. Tissue: Eye. |
| [10] | "Human collagen genes encoding basement membrane alpha 1 (IV) and alpha 2 (IV) chains map to the distal long arm of chromosome 13." Griffin C.A., Emanuel B.S., Hansen J.R., Cavenee W.K., Myers J.C. Proc. Natl. Acad. Sci. U.S.A. 84:512-516(1987) [PubMed: 3025878] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1451-1485. |
| [11] | "The arrangement of intra- and intermolecular disulfide bonds in the carboxyterminal, non-collagenous aggregation and cross-linking domain of basement-membrane type IV collagen." Siebold B., Deutzmann R., Kuehn K. Eur. J. Biochem. 176:617-624(1988) [PubMed: 2844531] [Abstract] Cited for: PROTEIN SEQUENCE OF 1480-1535; 1545-1614; 1617-1701 AND 1705-1712. Tissue: Placenta. |
| [12] | "Duplication of type IV collagen COOH-terminal repeats and species-specific expression of alpha 1(IV) and alpha 2(IV) collagen genes." Myers J.C., Howard P.S., Jelen A.M., Dion A.S., Macarak E.J. J. Biol. Chem. 262:9231-9238(1987) [PubMed: 2439508] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712. |
| [13] | "Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth." Kamphaus G.D., Colorado P.C., Panka D.J., Hopfer H., Ramchandran R., Torre A., Maeshima Y., Mier J.W., Sukhatme V.P., Kalluri R. J. Biol. Chem. 275:1209-1215(2000) [PubMed: 10625665] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712, FUNCTION. |
| [14] | Peng X., Sun W., Yin B., Yuan J., Qiang B. Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712. |
| [15] | "Molecular cloning and homologous sequence analysis of canstatin cDNA derived from Chinese hepatocytes." Li Y., Huang G., Qian G. Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712. Tissue: Hepatocyte. |
| [16] | "Cloning and expression of canstatin in yeast." Shan Z.X., Yu X.Y., Lin Q.X., Fu Y.H., Yang M., Tan H.H. Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712. |
| [17] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [18] | "The 1.9-A crystal structure of the noncollagenous (NC1) domain of human placenta collagen IV shows stabilization via a novel type of covalent Met-Lys cross-link." Than M.E., Henrich S., Huber R., Ries A., Mann K., Kuhn K., Timpl R., Bourenkov G.P., Bartunik H.D., Bode W. Proc. Natl. Acad. Sci. U.S.A. 99:6607-6612(2002) [PubMed: 12011424] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1485-1712. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AL139385, AL159153, AL161773 Genomic DNA. Translation: CAI17005.2. AL159153, AL139385, AL161773 Genomic DNA. Translation: CAH72050.2. AL161773, AL139385, AL159153 Genomic DNA. Translation: CAH71366.2. X05562 mRNA. Translation: CAA29076.1. M36963 Genomic DNA. Translation: AAA53099.1. J04217 Genomic DNA. Translation: AAA53097.1. X12784 Genomic DNA. Translation: CAA31275.1. M24766 mRNA. Translation: AAA52043.1. X05610 mRNA. Translation: CAA29098.1. BC080644 mRNA. Translation: AAH80644.1. J02760 mRNA. Translation: AAA58422.1. AF258350 mRNA. Translation: AAF72631.1. AF400430 mRNA. Translation: AAK92479.1. AY450357 mRNA. Translation: AAR20245.1. AY455978 mRNA. Translation: AAR18250.1. | |||||||||||||
| IPI | IPI00306322. | ||||||||||||
| PIR | CGHU2B. A32024. | ||||||||||||
| RefSeq | NP_001837.2. | ||||||||||||
| UniGene | Hs.508716 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P08572. 2 interactions. | ||||||||||||
| STRING | P08572. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P08572. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | P08572. | ||||||||||||
| PRIDE | P08572. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000360467; ENSP00000353654; ENSG00000134871; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 1284. | ||||||||||||
| KEGG | hsa:1284. | ||||||||||||
| UCSC | uc001vqx.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 1284. | ||||||||||||
| GeneCards | GC13P109757. | ||||||||||||
| HGNC | HGNC:2203. COL4A2. | ||||||||||||
| HPA | CAB010751. | ||||||||||||
| MIM | 120090. gene. | ||||||||||||
| PharmGKB | PA26718. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | P08572. | ||||||||||||
| HOVERGEN | P08572. | ||||||||||||
| OMA | QTDQEPM | ||||||||||||
| OrthoDB | EOG9Q2H0T | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_13552. Integrin cell surface interactions. REACT_16888. Signaling by PDGF. REACT_18266. Axon guidance. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P08572. | ||||||||||||
| Bgee | P08572. | ||||||||||||
| CleanEx | HS_COL4A2. | ||||||||||||
| Genevestigator | P08572. | ||||||||||||
| GermOnline | ENSG00000134871. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR016187. C-type_lectin_fold. IPR008160. Collagen. IPR001442. Collagen_VI_NC. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:2.170.240.10. Procollagn4_C. 1 hit. | ||||||||||||
| Pfam | PF01413. C4. 2 hits. PF01391. Collagen. 24 hits. [Graphical view] | ||||||||||||
| SMART | SM00111. C4. 2 hits. [Graphical view] | ||||||||||||
| PROSITE | PS51403. NC1_IV. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 5187. | ||||||||||||
| PMAP-CutDB | P08572. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CO4A2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P08572 Secondary accession number(s): Q14052 Q66K23 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 13 Human chromosome 13: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


